Understanding GLP-1 Inhibitors By now, most of us are familiar with GLP-1 medications like Ozempic (semaglutide), Wegovy (semaglutide), and Monjourno (tirzepatide), commonly used to treat type 2 diabetes and now weight loss
FDA approval is realistically a 2029 to 2030 event
However, protein requirements are calculated based on factors like age, gender, and activity level
The adoption of oral semaglutide resulted in a significant reduction in the use of sulfonylureas, pioglitazone, DPP4 inhibitors, and insulin, with no substantial change in the utilization of SGLT2 inhibitors
Glutathione (GSH) is the most important antioxidant in the human body
Deponte M, and Hell K